A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity.

In this study, we developed a multilayer microfluidic device to simulate nephron, which was formed by "glomerulus", "Bowman's capsule", "proximal tubular lumen" and "peritubular capillary". In this microdevice, artificial renal blood flow was circulating and glomerular filtrate flow was single passing through, mimicking the behavior of a nephron. In this dynamic artificial nephron, we observed typical renal physiology, including the glomerular size-selective barrier, glomerular basement membrane charge-selective barrier, glucose reabsorption and para-aminohippuric acid secretion. To demonstrate the capability of our microdevice, we used it to investigate the pathophysiology of drug-induced acute kidney injury (AKI) and give assessment of drug-induced nephrotoxicity, with cisplatin and doxorubicin as model drugs. In the experiment, we loaded the doxorubicin or cisplatin in the "renal blood flow", recorded the injury of primary glomerular endothelial cells, podocytes, tubular epithelial cells and peritubular endothelial cells by fluorescence imaging, and identified the time-dependence, dose-dependence and the death order of four types of renal cells. Then by measuring multiple biomarkers, including E-cadherin, VEGF, VCAM-1, Nephrin, and ZO-1, we studied the mechanism of cell injuries caused by doxorubicin or cisplatin. Also, we investigated the effect of BSA in the "renal blood flow" on doxorubicin-or-cisplatin-induced nephrotoxicity, and found that BSA enhanced the tight junctions between cells and eased cisplatin-induced nephrotoxicity. In addition, we compared the nephron model and traditional tubule models for assessment of drug-induced nephrotoxicity. And it can be inferred that our biomimetic microdevice simulated the complex, dynamic microenvironment of nephron, yielded abundant information about drug-induced-AKI at the preclinical stage, boosted the drug safety evaluation, and provided a reliable reference for clinical therapy.

[1]  Youhua Liu,et al.  Reno-Cerebral Reflex Activates the Renin-Angiotensin System, Promoting Oxidative Stress and Renal Damage After Ischemia-Reperfusion Injury. , 2017, Antioxidants & redox signaling.

[2]  Acute kidney injury , 2012, The Lancet.

[3]  Paul Vulto,et al.  Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening. , 2016, Trends in biotechnology.

[4]  Z. Dong,et al.  Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. , 2008, Kidney international.

[5]  N. Pannu,et al.  An overview of drug-induced acute kidney injury , 2008, Critical care medicine.

[6]  J. Bonventre,et al.  Biomarkers of acute kidney injury. , 2008, Annual review of pharmacology and toxicology.

[7]  William H Fissell,et al.  Albumin handling by renal tubular epithelial cells in a microfluidic bioreactor , 2012, Biotechnology and bioengineering.

[8]  Cynthia A. Naughton,et al.  Drug-induced nephrotoxicity , 2008 .

[9]  Haifeng Wang,et al.  A metabolic profiling analysis of the acute hepatotoxicity and nephrotoxicity of Zhusha Anshen Wan compared with cinnabar in rats using (1)H NMR spectroscopy. , 2013, Journal of ethnopharmacology.

[10]  V. Jha,et al.  Treatment-related acute renal failure in the elderly: a hospital-based prospective study. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  S. Alexander,et al.  Isolation and epithelial co-culture of mouse renal peritubular endothelial cells , 2014, BMC Cell Biology.

[12]  R. Bellomo,et al.  Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup , 2017 .

[13]  D. Ingber,et al.  Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[14]  M. Madaio,et al.  Isolation, culture, and characterization of endothelial cells from mouse glomeruli. , 2004, Kidney international.

[15]  R. Henning,et al.  Increased protein aggregation in Zucker Diabetic Fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide , 2014, BMC Cell Biology.

[16]  Xingyu Jiang,et al.  Engineering a 3D vascular network in hydrogel for mimicking a nephron. , 2013, Lab on a chip.

[17]  Yue Yu,et al.  A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice. , 2017, Lab on a chip.

[18]  Richard D Beger,et al.  Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. , 2010, Toxicology and applied pharmacology.

[19]  M. Faure,et al.  Adriamycin and adriamycin-DNA nephrotoxicity in rats. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[20]  F. Haddy,et al.  Acute renal failure and sepsis. , 2004, The New England journal of medicine.

[21]  R. Zeller,et al.  Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. , 1997, Experimental cell research.

[22]  R. Ireland.  Acute kidney injury: Alkaline phosphatase in sepsis-induced AKI , 2012, Nature Reviews Nephrology.

[23]  J. Bonventre,et al.  Acute Kidney Injury. , 2016, Annual review of medicine.

[24]  Joseph V Bonventre,et al.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.

[25]  Joseph V Bonventre,et al.  Biomarkers of nephrotoxic acute kidney injury. , 2008, Toxicology.

[26]  K. Maemura,et al.  Quantified kidney echogenicity in mice with renal ischemia reperfusion injury: evaluation as a noninvasive biomarker of acute kidney injury , 2017, Medical Molecular Morphology.

[27]  G. Whitesides,et al.  Soft lithography in biology and biochemistry. , 2001, Annual review of biomedical engineering.

[28]  Peng Huang,et al.  Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models. , 2014, Molecular pharmaceutics.

[29]  R. Frithiof,et al.  The novel nitric oxide donor PDNO attenuates ovine ischemia-reperfusion induced renal failure , 2017, Intensive Care Medicine Experimental.

[30]  Abraham Nyska,et al.  Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity , 2009, Toxicologic pathology.